» » »

Gene Mutation and Endometrial Cancer Boone NC

A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments. The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women#r3 with a highly aggressive form of the disease known as endometrioid endometrial cancer.

Appalachian - New River Veterinary Associates
(828) 264-5621
218 Wilson Dr
Boone, NC

Data Provided by:
Dean Steven Cohen
(828) 262-4200
336 Deerfield Rd
Boone, NC
Specialty
Family Practice

Data Provided by:
Marye Elizabeth Hacker
(828) 262-4399
336 Deerfield Rd
Boone, NC
Specialty
Family Practice, Emergency Medicine

Data Provided by:
Robert C Snyder
(828) 268-0064
237 Longvue Dr
Boone, NC
Specialty
Internal Medicine

Data Provided by:
John E Palmer
(828) 268-8951
336 Deerfield Rd
Boone, NC
Specialty
Internal Medicine

Data Provided by:
Charlie L Sykes
(828) 264-6362
108 Doctors Dr
Boone, NC
Specialty
Internal Medicine

Data Provided by:
Susan Elizabeth Murphey
(828) 262-4100
336 Deerfield Rd
Boone, NC
Specialty
Family Practice, Emergency Medicine

Data Provided by:
Joseph Walter Helak
(828) 264-9664
175 Mary St
Boone, NC
Specialty
Cardiology, Internal Medicine, Cardiovascular Disease

Data Provided by:
Sharon Kane Stafford
(828) 626-4100
336 Deerfield Rd
Boone, NC
Specialty
Family Practice, Emergency Medicine

Data Provided by:
Health & Wellness Initiatives
(828) 260-6297
409 Russelton Road
Boone, NC
Services
Women's Health, Weight Management, Supplements, Pediatrics, Nutrition, Mind/Body Medicine, Men's Health, Internal Medicine, Functional Medicine, Family Practice, Bio-identical HRT
Membership Organizations
American Holistic Medical Association

Data Provided by:
Data Provided by:

Gene Mutation and Endometrial Cancer

Provided By:

WEDNESDAY, May 27 (HealthDay News) -- A genetic marker for aggressive endometrial cancer has been identified by U.S. researchers, who said their finding could lead to more targeted and risk-appropriate treatments.

The researchers, from the Washington University School of Medicine in St. Louis, found that genetic mutation of the ATR gene in tumors boosts the risk of cancer recurrence and death in women with a highly aggressive form of the disease known as endometrioid endometrial cancer.

The ATR gene directs cellular responses to DNA damage, the researchers noted.

"Women whose endometrial cancers have an ATR mutation have more than four times the risk of having their cancer return," study author Dr. Israel Zighelboim, a gynecologic oncologist, said in a news release from the university. "This and similar tumor biomarkers could potentially identify those patients most in danger of recurrence and guide the development of treatments aimed at these more aggressive tumors."

ATR mutations were found in about 5 percent of the 248 endometrioid endometrial tumor samples analyzed by the researchers. Women with ATR mutations were 4.29 times more likely to have the cancer recur after treatment and 3.88 times more likely to die.

The study appears online in the Journal of Clinical Oncology.

Zighelboim and his research colleagues plan to see if the prognostic value of ATR mutations can be confirmed in a larger group of women and to investigate the association between ATR mutations and treatment response after cancer recurrence.

More information

The American Cancer Society has more about endometrial cancer.

SOURCE: Washington University School of Medicine in St. Louis, news release, May 26, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com